Derrell Porter - 19 May 2026 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Reporting relationship: Director
Issuer ticker: PASG
Reported as of: 19 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2026, 16:13:40 UTC
Prior SEC filing: 05 Jun 2025
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen Borthwick, Attorney-in-Fact

Key filing fact

Derrell Porter filed Form 4 for Passage BIO, Inc. (PASG) on 21 May 2026.

Key facts

This page summarizes Derrell Porter's Form 4 filing for Passage BIO, Inc. (PASG).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 May 2026, 16:13.

Change

Previous filing in this sequence was filed on 05 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001706400 Primary reporting owner

Porter Derrell

Relationship: Director
Address: ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA
Signature: /s/ Kathleen Borthwick, Attorney-in-Fact
Signature date: 21 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PASG transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value
Shares: +10,539
Change %
Price: $0.000000^*
Shares after: 10,539
Date: 19 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,539
Exercise price: $5.08
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2027 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.